A Biologic Joint Replacement Strategy to Treat Patients With Severe Knee

Status Completed

Clinical Trial Summary

With IRB approval and informed consent, patients (n=10) (18-50 years old) with post-traumatic knee OA and requiring a tibial plateau and meniscus arthroplasty plus a femoral condyle arthroplasty will be enrolled in the study. Primary criteria for inclusion will be Grade IV changes in the articular cartilage of the femoral condyle and tibial plateau and meniscal pathology in the medial or lateral femorotibial joint as determined by physical examination, diagnostic imaging and knee arthroscopy by the PI. Exclusion criteria include Grade III or IV changes in any other compartment of the knee, acute injury to any other part of the affected lower extremity, or inability to comply with the protocol. After enrollment, patients will undergo standardized knee radiography, and complete assessments (described below). Size-matched (standard clinical methodology) proximal tibia with meniscus and distal femur allografts from the same donor will be obtained from a tissue bank (Musculoskeletal Transplant Foundation, Edison, NJ) who has licensed the MOPS technology. The medial or lateral femoral condyle will be replaced using our novel instrumentation and technique described above. Tibial plateau-meniscus grafts will be trimmed and used to replace the entire medial or lateral tibial condyle while sparing the attachments of ACL, PCL and respective collateral ligament. The tibial plateau graft will be fixated using commercial available implants used for bone fixation. In the event that the meniscus has been detached from the tibial plateau during graft harvest, the periphery of the meniscus will be sutured to the capsule following standard meniscus transplant procedure. Patients will undergo controlled post-operative rehabilitation according to standard protocols for osteochondral with concurrent meniscus allografts. Range of motion, VAS pain score, SF-12, Tegner score, International Knee Documentation Committee (IKDC) subjective and objective scores, PROMIS Bank v1.2 - Physical Function-Mobility, PROMIS v1.1 - Global Health, PROMIS Bank v1.1- Pain Interference, PROMIS Bank v1.2 - Physical Function and Marx score as well as complete radiographs of the affected knee will be obtained prior to surgery and at 6 weeks, 3 months, 6 months, and 12 months after surgery to evaluate healing, function and evidence for arthrosis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03257371
Study type	Observational
Source	University of Missouri-Columbia
Contact
Status	Completed
Phase
Start date	December 30, 2016
Completion date	July 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05227924` - Safety and Performance Assessment of the SYMBOL Range of Medical Devices in Patients Underlying Total Hip Arthroplasty
Terminated	`NCT03275246` - Establish Implant Accuracy With X-PSI Knee System	N/A
Recruiting	`NCT05152758` - STABILITY: Physical Activity Intervention at 7 Years Post-Anterior Cruciate Ligament Reconstruction	N/A
Recruiting	`NCT06096259` - Preventing Injured Knees From osteoArthritis: Severity Outcomes	Phase 2
Recruiting	`NCT05456295` - Comparative Effect of Carbon Fiber Orthosis Cuff Design on Preference, Comfort, and Mechanics	N/A
Recruiting	`NCT05412381` - PRP in ACLR to Prevent PTOA	Phase 4
Recruiting	`NCT05848622` - Gait Rehabilitation to Treat FastOA	N/A
Recruiting	`NCT05306054` - Physical Activity, Knee Joint Loading and Joint Health
Completed	`NCT04589611` - Translating Metabolic Responses to Mechanical Insult Into Early Interventions to Prevent PTOA	Phase 1/Phase 2
Completed	`NCT04034043` - Ceramic-on-ceramic THA for Post-traumatic Hip Osteoarthritis After Acetabular Fracture
Active, not recruiting	`NCT04076202` - Clinical Evaluation of Vanguard DD RP	N/A
Completed	`NCT04562896` - Iterative Design of Custom Dynamic Orthoses to Reduce Articular Contact Stress	N/A
Recruiting	`NCT05603728` - Exactech Shoulder Post Market Clinical Follow-up Study
Recruiting	`NCT04875052` - Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury	N/A
Not yet recruiting	`NCT04033588` - Freedom® Total Knee System for Treatment of Osteoarthritis, Rheumatoid Arthritis or Post-traumatic Arthritis	N/A
Recruiting	`NCT03809520` - An Imaging Framework for Clinically Testing New Treatments to Prevent Post-traumatic OA	N/A
Active, not recruiting	`NCT05144191` - Insignia™ Hip Stem Outcomes Study	N/A
Recruiting	`NCT04572256` - MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate Ligament Reconstruction (MOCHA Trial)	Early Phase 1
Withdrawn	`NCT05209347` - Custom Dynamic Orthoses to Reduce Articular Contact Stress	N/A
Completed	`NCT01041937` - Total Knee Arthroplasty (TKA) Cemented Versus Cementless Tibial Prosthesis Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

A Biologic Joint Replacement Strategy to Treat Patients With Severe Knee Trauma and Post-Traumatic Knee Osteoarthritis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms